International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
Role of PRF and Interaction of Other Drugs in Implant Prostheses
| Author(s) | Dr. Ronika Nipana, Dr. Aanchal Kohli, Dr. Nilima Bukte, Sufiyan Ansari, Ashhad Ameen, Saquib Mehmood |
|---|---|
| Country | India |
| Abstract | Implant prosthodontics continues to develop rapidly with expanding treatment possibilities and improved biologic understanding of implant-supported rehabilitation. The long-term predictability of implant therapy depends largely on successful osseointegration, which is influenced by both local healing conditions and systemic pharmacological factors. Various drugs and biologic adjuncts can modify bone remodeling, angiogenesis, and tissue regeneration around implants. Platelet-rich fibrin (PRF) is an autologous platelet- and leukocyte-rich fibrin concentrate derived from blood that has shown regenerative potential because of its ability to release growth factors gradually during healing. In addition to PRF, several pharmacological agents such as antibiotics, anti-inflammatory drugs, bisphosphonates, statins, vitamin D, and bone-regulating molecules have been investigated for their influence on implant integration and peri-implant tissue response. PRF and its modifications, including advanced PRF and injectable PRF, together with platelet-rich plasma, have broadened regenerative applications in implant dentistry by improving wound healing, angiogenesis, and tissue maturation. This review discusses the biologic basis, preparation principles, clinical applications, advantages, limitations, and recent evidence regarding PRF and other pharmacological agents in implant prosthodontics, emphasizing their relevance as adjuncts in regenerative implant therapy and their role in evidence-based clinical practice. |
| Keywords | Platelet-rich fibrin, dental implants, osseointegration, implant prosthodontics, pharmacological agents |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 2, March-April 2026 |
| Published On | 2026-04-09 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals